Wall Street Experts
ver. ZuMIgo(08/25)
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd.
Rachunek Zysków i Strat
Przychody TTM (mln): 1 570
EBIT TTM (mln): 467
index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
Rok finansowy |
2013 |
2014 |
2015 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Przychód (mln) |
0 |
0 |
9 |
229 |
256 |
372 |
567 |
644 |
651 |
1,026 |
1,625 |
Przychód Δ r/r |
0.0% |
0.0% |
inf% |
2507.5% |
11.6% |
45.4% |
52.6% |
13.6% |
1.2% |
57.6% |
58.3% |
Marża brutto |
0.0% |
0.0% |
14.2% |
61.6% |
60.1% |
53.4% |
58.2% |
55.8% |
57.6% |
55.5% |
67.7% |
EBIT (mln) |
-16 |
-26 |
-30 |
57 |
31 |
68 |
144 |
128 |
125 |
184 |
448 |
EBIT Δ r/r |
0.0% |
57.0% |
17.2% |
-286.4% |
-44.5% |
115.7% |
112.1% |
-10.8% |
-2.7% |
47.2% |
144.0% |
EBIT (%) |
0.0% |
0.0% |
-345.9% |
24.7% |
12.3% |
18.3% |
25.4% |
19.9% |
19.2% |
17.9% |
27.6% |
Koszty finansowe (mln) |
0 |
0 |
0 |
7 |
9 |
7 |
12 |
6 |
9 |
16 |
35 |
EBITDA (mln) |
-12 |
-11 |
-15 |
86 |
67 |
109 |
242 |
234 |
245 |
324 |
691 |
EBITDA(%) |
0.0% |
0.0% |
-174.1% |
37.7% |
26.3% |
29.5% |
42.7% |
36.3% |
37.6% |
31.6% |
42.5% |
Podatek (mln) |
1 |
5 |
5 |
15 |
-13 |
9 |
27 |
17 |
0 |
8 |
39 |
Zysk Netto (mln) |
-14 |
-25 |
-30 |
42 |
44 |
49 |
123 |
115 |
129 |
163 |
404 |
Zysk netto Δ r/r |
0.0% |
84.5% |
19.9% |
-239.1% |
4.7% |
10.7% |
153.9% |
-6.5% |
11.9% |
26.2% |
148.2% |
Zysk netto (%) |
0.0% |
0.0% |
-343.5% |
18.3% |
17.2% |
13.1% |
21.8% |
17.9% |
19.8% |
15.9% |
24.9% |
EPS |
0.0 |
-0.5 |
-0.6 |
0.37 |
0.32 |
0.23 |
0.58 |
0.54 |
0.61 |
0.76 |
1.88 |
EPS (rozwodnione) |
0.0 |
-0.5 |
-0.6 |
0.37 |
0.32 |
0.23 |
0.58 |
0.54 |
0.61 |
0.76 |
1.84 |
Ilośc akcji (mln) |
0 |
50 |
50 |
113 |
137 |
213 |
213 |
213 |
213 |
213 |
215 |
Ważona ilośc akcji (mln) |
0 |
50 |
50 |
113 |
137 |
213 |
213 |
213 |
213 |
213 |
220 |
Waluta |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |